Genetic polymorphism of KIR2DL4 (CD158d), a putative NK cell receptor for HLA-G, does not influence susceptibility to asthma

Tissue Antigens

Volumn 82, Issue 4, 2013, Pages 276-279

  Le Page, M E L ^a   Goodridge, J P ^b   Zhang, G ^a   Holt, P G ^c,d   Sly, P ^d   Witt, C S ^a,e  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Asthma; Atopy; CD158d; KIR2DL4

Indexed keywords

GAMMA INTERFERON; HLA G ANTIGEN; IMMUNOGLOBULIN E; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4;

ADOLESCENT; ARTICLE; ASTHMA; ATOPY; BRONCHUS REACTIVITY; CHILD; CYTOKINE RELEASE; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ASTHMA; ATOPY; CD158D; KIR2DL4;

ADOLESCENT; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; HLA-G ANTIGENS; HUMANS; IMMUNOGLOBULIN E; INFANT; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, GENETIC; RECEPTORS, KIR2DL4; RESPIRATORY MUCOSA;

EID: 84890858612     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12185     Document Type: Article

References (25)

1. Rajagopalan S, Fu J, Long EO. Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 2001: 167: 1877-81.
2. Yan WH, Fan LA. Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition. Cell Res 2005: 15: 176-82.
3. Rajagopalan S, Bryceson YT, Kuppusamy SP et al. Activation of NK Cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2005: 4: e9.
4. Cantoni C, Verdiani S, Falco M et al. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily [published erratum appears in Eur J Immunol 1998 Oct;28(10):3398]. Eur J Immunol 1998: 28: 1980-90.
5. Yu YR, Tian XH, Wang Y, Feng MF. Rapid production of human KIR2DL4 extracellular domain and verification of its interaction with HLA-G. Biochem Mosc 2005: 71: S60-4.
6. Allan DS, Colonna M, Lanier LL et al. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med 1999: 189: 1149-56.
7. Boyson JE, Erskine R, Whitman MC et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci USA 2002: 99: 16180-5.
8. Nicolae D, Cox NJ, Lester LA et al. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 2005: 76: 349-57.
9. Moffatt MF, Gut IG, Demenais F et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010: 363: 1211-21.
10. Zhou H, Hong X, Jiang S, Dong H, Xu X, Xu X. Analyses of associations between three positionally cloned asthma candidate genes and asthma or asthma-related phenotypes in a Chinese population. BMC Med Genet 2009: 10: 123.
11. Hviid TV, Hylenius S, Rorbye C, Nielsen L. G.HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003: 55: 63-79.
12. McMaster MT, Librach CL, Zhou Y et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 1995: 154: 3771-8.
13. Gregori S, Tomasoni D, Pacciani V et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 2010: 116: 935-44.
14. LeMaoult J, Le Discorde M, Rouas-Freiss N et al. Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 2003: 62: 273-84.
15. White SR, Loisel DA, McConville JF et al. Levels of soluble human leukocyte antigen-G are increased in asthmatic airways. Eur Respir J 2010: 35: 925-7.
16. Goodridge JP, Lathbury LJ, Steiner NK et al. Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells. Eur J Immunol 2007: 37: 199-211.
17. Goodridge JP, Witt CS, Christiansen FT, Warren HS. KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol 2003: 171: 1768-74.
18. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 2003: 21: 713-58.
19. Vacca P, Cantoni C, Vitale M et al. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression. Proc Natl Acad Sci USA 2010: 107: 11918-23.
20. Witt CS, Whiteway JM, Warren HS et al. Alleles of the KIR2DL4 receptor and their lack of association with pre-eclampsia. Eur J Immunol 2002: 32: 18-29.
21. Kusel MM, de Klerk NH, Kebadze T et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007: 119: 1105-10.
22. Holt PG, Rudin A, Macaubas C et al. Development of immunologic memory against tetanus toxoid and pertactin antigens from teh diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children. J Allergy Clin Immunol 2000: 105: 1117-22.
23. Newnham JP, Evans SF, Michael CA, Stanley FJ, Landau LI. Effects of frequent ultrasound during pregnancy: a randomised controlled trial. Lancet 1993: 342: 887-91.
24. Joseph-Bowen J, de Klerk NH, Firth MJ, Kendall GE, Holt PG, Sly PD. Lung function, bronchial responsiveness, and asthma in a community cohort of 6-year-old children. Am J Respir Crit Care Med 2004: 169: 850-4.
25. John E, Christiansen FT, Mueller I et al. Distinct distribution of killer-cell immunoglobulin-like receptor genes in the Mugil and Ilaita areas of Papua New Guinea. Tissue Antigens 2012: 79: 263-71.